diagnost tool
deliv anoth good quarter pt
deliv anoth good quarter basic line us street
top line posit surpris came bottom line fuel strong margin
benefit realiz result favor product mix delay project
spend rais full-year om guid fxn improv
previous rais bottom line guid call
growth fxn basi indic saw chang
competit front consist think reiter buy rate
rais pt
highlight strong margin beat rev rep organ
narrowli beat our/street highlight came margin gm
y/i beat product mix gain lpd om
y/i beat exp came us slight push-
 project spend adj ep rep fxn beat our/
surpris segment growth deliv segment growth match
estim includ growth fxn net global deliv
organ growth consum organ growth refer
lab growth softwar growth rapid assay instrument declin
organ due difficult prior year comp water busi remain healthi
organ off-set lpd organ us import metric
robust consum growth integr buy thesi
guid reiter revenue guid rep
fxn y/i initi revenue guid rep org
prior estim midpoint given beat rais
adj ep guid rep fxn
rep fxn remind easier growth comp
extra busi day
revamp patient data highlight call show patient
practic data practic prepar help animalytix
lead anim health data firm broke clinic visit growth total visit
growth note total visit rebound vs revis
clinic visit grew importantli total practic revenu
grew suggest us visit bounc around quarter-to-quart
practic revenu fairli stabl rang year suggest stabl
healthi clinic growth
model rais rev report currenc
neutral basi carri forward beat lower
revenue estim move line
compani guid rais om primarili build
beat rais adj ep y/i prior
rais adj ep estim y/i
bull thesi big pictur intact see next page
global leader anim health diagnost
instrument lab test softwar sell direct
global sale rep
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
big pictur core compon buy thesi driven multi-year
opportun grow busi ou think intern anim health
diagnost market grow current size analyst day initi
surpris anim diagnost revenu spend target billion compound-annual-growth-rate
billion led growth ou us
think could grow revenu faster year
near-term potenti growth driver includ limit
lack meaning competitor ou refer lab busi solid demand
lab test world-wide earli phase newer product launch integr
challeng zoetis/abaxi may allow execut even better near-
term traction new us ou sale rep push toward prevent
well test rather sickcar greater anim health dx util
result millennial-ag pet owner addit veterinarian
link note follow recent investor meet manag
link takeaway compani analyst day last august
buy unchang target price may
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price may
diagnost tool
buy unchang target price may
diagnost tool
